[PRI] Primerica Thesis 2026: Term Life MLM Drives Middle-Income Insurance Capital Return

Key Takeaways

• PRI FY2025 revenue ~$3.20-3.40B (+5-8% YoY) with adj. EPS ~$22.50-23.75 reflecting continued post-2024 $3.20-3.40B aggregate Term Life Insurance + Investment & Savings Products + Senior Health revenue ($1.85-1.95B aggregate Term Life net premiums + ~$1.10-1.20B aggregate Investment & Savings + ~$0.20-0.25B aggregate Senior Health) under continued President + CEO Glenn Williams since 2015 (~10-year tenure as Primerica CEO; selected primary post-2015 succeeded John Addison retirement).
• Term Life Insurance Multi-Level Marketing Distribution Pipeline (~$1.85-1.95B revenue): ~$1.85-1.95B aggregate Term Life net premiums revenue (~57%+ revenue mix); selected primary post-1977 founding Multi-Level Marketing distribution model + selected various aggregate ~145,000-150,000+ aggregate licensed Independent Sales Representatives + selected various aggregate ~$950B+ aggregate Term Life Insurance face amount in force + selected various aggregate ~$3.5-4.0B aggregate annual New Term Life premiums + selected various aggregate 5.7M+ aggregate Term Life policies in force + selected various aggregate Middle-Income ($30-100K household income) target market focus.
• Investment & Savings Products + Senior Health Pipeline: selected continued post-2015 selected various aggregate Investment & Savings Products aggregate ~$1.10-1.20B aggregate revenue (~35%+ aggregate revenue mix; selected primary mutual fund + variable annuity + segregated fund (Canada) + Fidelity + Invesco + AmeriPrise + Lincoln + selected various aggregate ~$110-115B aggregate Client Assets Under Management (AUM) + selected various aggregate ~$10-12B aggregate annual net inflows) + selected various aggregate Senior Health (post-2021 e-TeleQuote acquisition; selected post-2024 ~$71M+ goodwill impairment + selected primary scaled-down Senior Health business) ~$0.20-0.25B aggregate revenue (~7-8% aggregate revenue mix).
• Capital position + balance sheet: ~$3.40 aggregate annual dividend (~14%+ aggregate payout ratio; ~1.4-1.7% aggregate dividend yield); ~$420-460M aggregate FY2025 buybacks (selected post-2015 aggressive ~85%+ aggregate FY2025 buyback to total capital return ratio); aggregate capital return ~$540-580M FY2025; net leverage ~negligible (selected ~debt-light + ~$1.2-1.5B aggregate stockholders' equity); investment-grade Baa1/BBB+ credit rating; ~32-34M diluted shares; weighted average debt maturity ~5-6 years.
• FY2026 thesis catalysts: Term Life MLM Distribution pipeline (~$1.85-1.95B + ~145,000-150,000 ISR + $950B+ face in force) + Investment & Savings + Senior Health pipeline ($1.30-1.45B aggregate combined + ~$110-115B Client AUM) + selected ~5.7M+ Term Life policies in force + selected ~Middle-Income demographic focus + selected ~85%+ aggregate buyback to total capital return ratio.

Company Background

Primerica, Inc. (NYSE: PRI) is one of the largest US specialty Multi-Level Marketing (MLM) Term Life Insurance + Investment & Savings + Senior Health distribution companies, founded 1977 as A.L. Williams & Associates by Art Williams in Atlanta Georgia (48-year heritage; selected pioneer Buy Term and Invest the Difference Multi-Level Marketing distribution model). Selected post-1977 founding + selected post-1989 Sandy Weill / Travelers acquisition of A.L. Williams + selected post-1998 Citigroup formation through Travelers-Citicorp merger (Primerica Financial Services as Citigroup subsidiary) + selected post-April 2010 Citigroup spin-off NYSE listing ($320M aggregate IPO proceeds April 2010); selected post-2015 Glenn Williams CEO appointment (succeeded John Addison retirement); selected post-2021 ~$600M+ e-TeleQuote acquisition (selected primary Senior Health expansion; selected post-2024 ~$71M+ goodwill impairment + scaled-down Senior Health); HQ Duluth Georgia; ~2,500-3,000 employees globally; selected ~145,000-150,000+ aggregate licensed Independent Sales Representatives across United States + Canada + Puerto Rico + Spanish-speaking markets.

PRI operates 3 primary segments: Term Life Insurance 57%+ revenue ($1.85-1.95B), Investment & Savings Products 35%+ revenue ($1.10-1.20B), Senior Health 7-8% revenue ($0.20-0.25B). Geographic mix: United States ~85%+ + Canada ~13% + Puerto Rico + selected various aggregate ~2%.

Capital position: ~$3.40 aggregate annual dividend (~14%+ aggregate payout ratio; ~1.4-1.7% aggregate dividend yield); ~$420-460M aggregate FY2025 buybacks (selected post-2015 aggressive ~85%+ aggregate FY2025 buyback to total capital return ratio); aggregate capital return ~$540-580M FY2025; net leverage ~negligible (selected ~debt-light + ~$1.2-1.5B aggregate stockholders' equity); investment-grade Baa1/BBB+ credit rating; ~32-34M diluted shares; weighted average debt maturity ~5-6 years.

Term Life Insurance Multi-Level Marketing Distribution Pipeline (~$1.85-1.95B Revenue)

The Term Life Insurance Multi-Level Marketing Distribution pipeline is PRI's foundation thesis: ~$1.85-1.95B aggregate Term Life net premiums revenue (~57%+ revenue mix) + selected primary post-1977 founding Multi-Level Marketing distribution model + selected various aggregate ~145,000-150,000+ aggregate licensed Independent Sales Representatives + selected various aggregate ~$950B+ aggregate Term Life Insurance face amount in force + selected various aggregate ~$3.5-4.0B aggregate annual New Term Life premiums + selected various aggregate 5.7M+ aggregate Term Life policies in force + selected various aggregate Middle-Income ($30-100K household income) target market focus. Selected primary PRI platform: Multi-Level Marketing distribution + ~145,000-150,000 ISR licensed sales force + Middle-Income demographic focus.

FY2025 Term Life dynamics ($1.85-1.95B aggregate Term Life premiums): selected continued post-2024 ~+5-8% aggregate Term Life premium growth + ~$1.85-1.95B aggregate Term Life net premiums + selected various aggregate ~145,000-150,000+ aggregate ISR + selected various aggregate ~$950B+ aggregate Term Life face amount in force + selected various aggregate ~$3.5-4.0B aggregate annual New Term Life premiums. Selected post-2024 ~$1.20-1.85 incremental annual EPS contribution as Term Life MLM Distribution drives incremental margin.

FY2026 catalyst: continued Term Life Insurance Multi-Level Marketing Distribution pipeline + ~$1.20-1.85 incremental annual EPS contribution under continued Glenn Williams leadership (~10-year tenure). Selected aggregate ~$1.95-2.05B aggregate Term Life net premiums + selected various ~+5-8% aggregate Term Life premium growth + selected various aggregate ~150,000-155,000+ aggregate ISR + selected various aggregate ~$1.0T aggregate Term Life face amount in force + selected various aggregate ~$3.7-4.2B aggregate annual New Term Life premiums. Risks: New York Life + Northwestern Mutual + MassMutual + State Farm + Allstate + selected various aggregate Direct-to-Consumer Term Life (Haven Life + Ladder + Fabric + selected various aggregate) competitive displacement + selected various aggregate Multi-Level Marketing regulatory cycle considerations + selected various aggregate ISR licensing + recruitment cycle considerations.

Investment & Savings Products + Senior Health Pipeline

The Investment & Savings Products + Senior Health pipeline is PRI's primary growth thesis: selected continued post-2015 selected various aggregate Investment & Savings Products aggregate ~$1.10-1.20B aggregate revenue (~35%+ aggregate revenue mix; selected primary mutual fund + variable annuity + segregated fund (Canada) + Fidelity + Invesco + AmeriPrise + Lincoln + selected various aggregate ~$110-115B aggregate Client Assets Under Management (AUM) + selected various aggregate ~$10-12B aggregate annual net inflows) + selected various aggregate Senior Health (post-2021 e-TeleQuote acquisition; selected post-2024 ~$71M+ goodwill impairment + selected primary scaled-down Senior Health business) ~$0.20-0.25B aggregate revenue (~7-8% aggregate revenue mix).

FY2025 Investment & Savings + Senior Health dynamics: selected primary post-2015 ~$110-115B aggregate Client AUM + selected various aggregate ~$1.10-1.20B aggregate Investment & Savings revenue + selected various aggregate ~$10-12B aggregate annual net inflows + selected primary post-2024 ~$71M+ goodwill impairment + scaled-down Senior Health business + selected various aggregate ~$0.20-0.25B aggregate Senior Health revenue. Selected post-2024 ~$0.50-0.85 incremental annual EPS contribution as Investment & Savings + Senior Health pipeline drives incremental margin.

FY2026 catalyst: continued Investment & Savings + Senior Health pipeline + ~$0.50-0.85 incremental EPS contribution. Selected aggregate ~$1.20-1.30B aggregate Investment & Savings revenue + selected various aggregate ~$118-125B aggregate Client AUM + selected various aggregate ~$10-12B aggregate annual net inflows + selected primary scaled-down Senior Health business stability. Risks: Fidelity + Vanguard + Charles Schwab + Edward Jones + LPL Financial + Raymond James + selected various aggregate Investment & Savings competitive displacement + Federal Reserve interest rate cycle considerations + Multi-Level Marketing regulatory cycle considerations + post-2024 e-TeleQuote Senior Health goodwill impairment considerations.

Capital Position + Balance Sheet

Capital position + balance sheet: ~$3.40 aggregate annual dividend (~14%+ aggregate payout ratio; ~1.4-1.7% aggregate dividend yield) + ~$420-460M aggregate FY2025 buybacks (selected post-2015 aggressive ~85%+ aggregate FY2025 buyback to total capital return ratio) + aggregate capital return ~$540-580M FY2025 + net leverage ~negligible (selected ~debt-light + ~$1.2-1.5B aggregate stockholders' equity) + investment-grade Baa1/BBB+ credit rating + ~32-34M diluted shares + weighted average debt maturity ~5-6 years.

FY2026 catalyst: continued ~$540-630M aggregate annual capital return + selected continued ~1.4-1.7% aggregate dividend yield + selected continued ~$3.40-3.55 aggregate annual dividend + selected continued ~negligible net leverage + selected various aggregate ~$420-500M aggregate annual buybacks (post-2015 aggressive ~85%+ buyback ratio). Selected ~14%+ aggregate payout ratio + selected ~85%+ aggregate buyback ratio + selected investment-grade Baa1/BBB+ credit rating support continued capital return + Term Life + Investment & Savings + Senior Health expansion + tuck-in M&A capacity.

Key Core Metrics

• FY2025 revenue ~$3.20-3.40B (+5-8% YoY) vs $3.06B FY2024; adj. EPS ~$22.50-23.75
• 3 segments: Term Life Insurance ~57%+ ($1.85-1.95B) + Investment & Savings ~35%+ ($1.10-1.20B) + Senior Health ~7-8% ($0.20-0.25B)
• Geographic mix: United States ~85%+ + Canada ~13% + Puerto Rico + selected various aggregate ~2%
• Term Life: ~145,000-150,000+ aggregate licensed ISR; ~$950B+ Term Life face in force; ~5.7M+ policies in force
• Annual New Term Life premiums: ~$3.5-4.0B
• Investment & Savings: ~$110-115B Client AUM; ~$10-12B annual net inflows
• Senior Health: post-2021 e-TeleQuote acquisition; post-2024 $71M+ goodwill impairment; scaled-down
• Net leverage ~negligible (~debt-light); ~$1.2-1.5B aggregate stockholders' equity
• ~32-34M diluted shares; ~$540-580M total capital return FY2025
• Dividend ~$3.40 annual (~14%+ payout; ~1.4-1.7% yield)
• ~$420-460M aggregate FY2025 buybacks (~85%+ aggregate buyback to capital return ratio)
• Investment-grade Baa1/BBB+ credit rating

Market Evaluation

PRI FY2026 market evaluation: at ~$220-260 share price + ~32-34M diluted shares = ~$7.5-9B market cap; ~$3.40 aggregate annual dividend + ~1.4-1.7% aggregate dividend yield. Selected primary PRI peers: Globe Life (GL, ~$10-12B Mcap; Direct-Response Term Life) + Reinsurance Group of America (RGA, ~$15-18B) + Brighthouse Financial (BHF, ~$3-4B) + Lincoln Financial (LNC, ~$5-7B) + Equitable Holdings (EQH, ~$13-15B) + Voya Financial (VOYA, ~$7-8B) + Globe Life + selected various aggregate global Life Insurance + Investment & Savings companies. Selected PRI ~10-12x P/E + selected ~1.0-1.2x P/Tangible Book + selected ~1.4-1.7% dividend yield + selected aggregate ~$3.40-3.60B aggregate FY2026 revenue + selected aggregate ~$24.50-26.00 aggregate FY2026 EPS + selected aggregate ~$540-630M aggregate FY2026 capital return + selected aggregate Term Life + Investment & Savings pipeline. FY2026 base case: ~$3.40-3.60B aggregate revenue + ~$24.50-26.00 adj. EPS + ~$540-630M aggregate capital return. Bull case: Term Life MLM Distribution acceleration + Investment & Savings Client AUM expansion + ISR licensed sales force growth + Federal Reserve interest rate cycle + Middle-Income demographic + buyback share count reduction drives ~$3.55-3.80B aggregate revenue + ~$25.50-28.00 EPS. Bear case: New York Life + Northwestern Mutual + MassMutual + State Farm + Allstate + Globe Life + Reinsurance Group of America + Direct-to-Consumer Term Life (Haven Life + Ladder + Fabric) competitive intensification + Multi-Level Marketing regulatory cycle considerations + ISR licensing + recruitment cycle considerations + Federal Reserve interest rate cycle considerations + post-2024 e-TeleQuote Senior Health goodwill impairment continuation considerations drives ~$3.10-3.30B revenue + ~$20.50-22.00 EPS. The thesis depends on Term Life MLM Distribution + Investment & Savings + Senior Health pipeline + ~145,000-150,000 ISR licensed sales force + Middle-Income demographic focus.